Disease-free survival after surgical resection of lung carcinoma in situ has been reported as over 90%. After resection of stage IA non-small cell lung cancer, survival at 5 years is approximately 60% to 70%. If endoscopic or bronchoscopic treatments of early-stage lung cancer can provide similar disease-free survival with less perioperative mortality, morbidity, and cost, then they may be alternative front-line therapies.
Methods
The authors review early-stage lung cancer detection by fluorescence bronchoscopy and the potential treatment of this disease by endoscopic techniques (photodynamic therapy, brachytherapy, Nd:YAG laser, electrocautery, and cryotherapy).
Results
Several reports have noted improved outcomes using endoscopic therapies for early-stage lung cancer, but insufficient data preclude firm conclusions regarding the role of fluorescence bronchoscopy, endobronchial brachytherapy, or electrocautery in early-stage lung cancer. Other than resection, photodynamic therapy may represent the best approach at this time. The principal indication for laser bronchoscopy is palliation of central airway obstruction
Conclusions
The identification of early-stage lung cancer provides no advantage if we have little to offer the patient short of traditional therapy. The value of newer treatment techniques and methods requires verification.
References
1.
MountainC.F.Revisions in the international system for staging lung cancer. Chest.1997; 111: 1710–1717.
2.
ColbyT.V., KossM., TraussW., eds. Atlas of Tumor Pathology.3rd ed.Washington, DC: Armed Forces Institute of Pathology; 1994: 145–155.
3.
SaccomannoG.Carcinoma in situ of the lung: its development, detection, and treatment. Semin Respir Med.1982; 4: 156–160.
4.
RisseE.K., VooijsG.P., van't HofM.A.Diagnostic significance of “severe dysplasia” in sputum cytology. Acta Cytol.1988; 32: 629–634.
5.
CorteseD.A., EdellE.S.Role of phototherapy, laser therapy, brachytherapy, and prosthetic stents in the management of lung cancer. Clin Chest Med.1993; 14: 149–159.
6.
WoolnerL.B., FontanaR.S., CorteseD.A.Roentgenographically occult lung cancer: pathologic findings and frequency of multicentricity during a 10-year period. Mayo Clin Proc.1984; 59: 453–466.
7.
NagamotoN., SaitoY., SatoM.Clinicopathological analysis of 19 cases of isolated carcinoma in situ of the bronchus. Am J Surg Path.1993; 17: 1234–1243.
8.
HayataY., KatoH., AmemiyaR.Indications of photoradiation therapy in early stage lung cancer on the basis of post-PRT histologic findings. Prog Clin Biol Res.1984; 170: 747–758.
9.
IshidaT., InoueT., SugioK.Early squamous lung cancer and longer survival rates. Respiration.1993; 60: 359–365.
10.
WoolnerL.B., DavidE., FontanaR.S.In situ and early invasive bronchogenic carcinoma: report of 28 cases with postoperative survival data. J Thorac Cardiovasc Surg.1970; 60: 275–290.
11.
CorteseD.A., KinseyJ.H., WoolnerL.B.Clinical application of a new endoscopic technique for detection of in situ bronchial carcinoma. Mayo Clin Proc.1979; 54: 635–641.
12.
ProfioA.E., DoironD.R., BalchumO.J.Fluorescence bronchoscopy for localization of carcinoma in situ. Med Phys.1983; 10: 35–39.
13.
PalcicB., LamS., HungJ.Detection and localization of early lung cancer by imaging techniques. Chest.1991; 99: 742–743.
14.
SteppH., BaumgartnerR., BetzC.New developments in fluorescence detection of ALA-induced protoporphyrin IX for cancer detection. Soc Photo-Opt Instrum Eng.1997; 3197: 68–74.
15.
BaumgartnerR., HuberR.M., SchulzH.Inhalation of 5-aminolevulinic acid: a new technique for fluorescence detection of early stage lung cancer. J Photochem Photobiol B.1996; 36: 169–174.
16.
LamS., MacAulayC., HungJ.Detection of dysplasia and carcinoma in situ with a lung imaging fluorescence endoscope device. J Thorac Cardiovasc Surg.1993; 105: 1035–1040.
17.
LamS., KennedyT., UngerM.Localization of bronchial intra epithelial neoplastic lesions by fluorescence bronchoscopy. Chest.1998; 113: 696–702.
18.
KurieJ.M., LeeJ.S., MoriceR.C.Autofluorescence bronchoscopy in the detection of squamous metaplasia and dysplasia in current and former smokers. J Natl Cancer Inst.1998; 90: 991–995.
HayataY., KatoH., KonakaC.Fiberoptic bronchoscopic laser photoradiation for tumor localization in lung cancer. Chest.1982; 82: 10–14.
21.
EdellE.S., CorteseD.A.Photodynamic therapy: its use in the management of bronchogenic carcinoma. Clin Chest Med.1995; 16: 455–463.
22.
SutedjaT., PostmusP.E.Photodynamic therapy in lung cancer: a review. J Photochem Photobiol B.1996; 36: 199–204.
23.
HayataY., KatoH., KonakaC.Photoradiation therapy with hematoporphyrin derivative in early and stage 1 lung cancer. Chest.1984; 86: 169–177.
24.
EdellE.S., CorteseD.A.Bronchoscopic phototherapy with hematoporphyrin derivative for treatment of localized bronchogenic carcinoma: a 5-year experience. Mayo Clin Proc.1987; 62: 8–14.
25.
MonnierP., SavaryM., FontollietC.Photodetection and photodynamic therapy of “early” squamous cell carcinomas of the pharynx, oesophagus, and tracheobronchial tree. Lasers Med Sci.1990; 5: 149–169.
McCaughanJ.S.Jr, WilliamsT.E.Photodynamic therapy for endobronchial malignant disease: a prospective fourteen- year study. J Thorac Cardiovasc Surg.1997; 114: 940–947.
28.
CorteseD.A., EdellE.S., KinseyJ.H.Photodynamic therapy for early stage squamous cell carcinoma of the lung. Mayo Clin Proc.1997; 72: 595–602.
29.
HenschkeU.K., HilarisB.S., MahanG.D.Remote afterloading with intracavitary applicators. Radiology.1964; 83: 344–345.
30.
MoylanD., StrublerK., UnalA.Transbronchial brachytherapy of recurrent bronchogenic carcinoma: a new approach using the flexible fiberoptic bronchoscope. Radiology.1983; 147: 253–254.
31.
SheskiF.D., MathurP.N.Cryotherapy, electrocautery, and brachytherapy. Clin Chest Med.1999; 20: 123–138.
32.
MachaH.N., WahlersB., ReichleC.Endobronchial radiation therapy for obstructing malignancies: ten years’ experience with iridium-192 high-dose radiation brachytherapy afterloading technique in 365 patients. Lung.1995; 173: 271–280.
33.
SutedjaG., BarisG., van ZandwijkN.High-dose rate brachytherapy has a curative potential in patients with intraluminal squamous cell lung cancer. Respiration.1994; 61: 167–168.
34.
TredanielJ., HennequinC., ZalcmanG.Prolonged survival after high-dose rate endobronchial radiation for malignant airway obstruction. Chest.1994; 105: 767–772.
35.
PerolM., CaliandroR., PommierP.Curative irradiation of limited endobronchial carcinomas with high-dose rate brachytherapy: results of a pilot study. Chest.1997; 111: 1417–1423.
36.
NoriD., AllisonR., KaplanB.High dose-rate intraluminal irradiation in bronchogenic carcinoma: technique and results. Chest.1993; 104: 1006–1011.
37.
LaforetE.G., BergerR.L., VaughanC.W.Carcinoma obstructing the trachea: treatment by laser resection. N Engl J Med.1976; 294: 941.
GerasinV.A., LevashorY.N., ShafirovscyB.B.Bronchoscopic laser photocoagulation of superficial cancer of the bronchi. Chest.1990; 98: 235–236.
40.
CavaliereS., FoccoliP., ToninelliC.Nd: YAG laser therapy in lung cancer: an 11-year experience with 2253 applications in 1585 patients. J Bronchol.1994; 1: 105–111.
41.
KernanJ.D.Carcinoma of the lung and bronchus: treatment with radon implants and diathermy. Arch Otolaryngol.1933; 17: 457–473.
42.
MoerschH.J., BowingH.H.Primary carcinoma of the bronchus treated successfully with surgical diathermy. Ann Surg.1935; 102: 989–994.
43.
van BoxemT.J., VenmansB.J., SchramelF.M.Radiographically occult lung cancer treated with fiberoptic bronchoscopic electrocautery: a pilot study of a simple and inexpensive technique. Eur Respir J.1998; 11: 169–172.
44.
MathurP.N., WolfK.M., BuskM.F.Fiberoptic bronchoscopic cryotherapy in the management of tracheobronchial obstruction. Chest.1996; 110: 718–723.
45.
OzenneG., VergnonJ.M., RoullierA.Cryotherapy of in situ or microinvasive bronchial carcinoma. Chest.1990; 98: 1058.
